Targeting multidrug resistance protein 1 (MDR1) enhances the efficacy of Smac-mimetic-based therapy in Acute Myeloid Leukaemia.
GA ID:
Agency:
Cancer Australia
Publish Date:
3-Jul-2019
Category:
Cancer
Grant Term:
1-Jun-2019
to
31-May-2022
Value (AUD):
$361,023.00
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Last Updated:
3-Jul-2019 11:42 am (ACT Local Time)